Product
SUNPG18_07
Aliases
SUNPG18_07 I, SUNPG18_07 II, SUNPG18_07 III
1 clinical trial
1 indication
Indication
Psoriatic ArthritisClinical trial
A Long-Term Extension Study to Demonstrate Safety of Tildrakizumab in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.Status: Completed, Estimated PCD: 2023-09-18